• Molecular NameAspirin
  • SynonymNA
  • Weight180.159
  • Drugbank_IDDB00945
  • ACS_NO50-78-2
  • Show 2D model
  • LogP (experiment)1.19
  • LogP (predicted, AB/LogP v2.0)1.39
  • pka3.5
  • LogD (pH=7, predicted)-2.01
  • Solubility (experiment)3.33 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)0.74
  • LogSw (predicted, AB/LogsW2.0)2.66
  • Sw (mg/ml) (predicted, ACD/Labs)2.38
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds3
  • TPSA63.6
  • StatusFDA approved
  • AdministrationMost commonly oral, also rectal. Lysine acetylsalicylate may be given IV or IM
  • PharmacologyA salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication.
  • Absorption_value91.0
  • Absorption (description)Readily absorbed after oral administration
  • Caco_2N/A
  • Bioavailability53.5
  • Protein binding99.5
  • Volume of distribution (VD)0.15 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • Metabollsm80% of therapeutic doses of salicylic acid is metabolized in the liver.
  • Half life0.25 h
  • ExcretionSalicylates are excreted mainly by the kidneys as salicyluric acid (75%), free salicylic acid (10%), salicylic phenol (10%) and acyl (5%) glucuronides, and gentisic acid (< 1%).
  • Urinary Excretion1.4
  • Clerance9.3 ml.min-1.kg-1
  • ToxicityOral, mouse: LD50 = 250 mg/kg; Oral, rabbit: LD50 = 1010 mg/kg; Oral, rat: LD50 = 200 mg/kg. Effects of overdose include: tinnitus, abdominal pain, hypokalemia, hypoglycemia, pyrexia, hyperventilation, dysrhythmia, hypotension, hallucination, renal failure, confusion, seizure, coma, and death.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A